https://www.selleckchem.com/pr....oducts/bay-1217389.h
Proliferative diabetic retinopathy (PDR) is a leading cause of blindness. This study aimed to analyze the expression of the erythropoietin receptor (EpoR) in patients with PDR and its correlation with postoperative visual prognosis. Between May 2016 and May 2017, 89 patients who underwent vitreoretinal surgery (VRS) in Affiliated Hospital of North Sichuan Medical College were enrolled. Among them, 45 patients (52 eyes) with PDR and 44 patients (50 eyes) with retinal vein occlusion (RVO) made up the study group and the control group,